<?xml version="1.0" encoding="UTF-8"?>
<p id="par0060">The ACDC has taken up a coordinated continental perspective to define strategies that can address some of the challenges impeding the derivation of full benefits from currently available technologies that will facilitate interventions against SARS-CoV-2 and future emerging pathogens (
 <xref rid="bib0005" ref-type="bibr">ACDC, 2020</xref>). The larger goal is to set up centralised genomics laboratory hubs, coordinated by the Pathogen Genomics Intelligence Institute (
 <xref rid="bib0005" ref-type="bibr">ACDC, 2020</xref>). The main goal is to strengthen and link health systems with these institutions for the effective surveillance, detection, tracking and monitoring of outbreaks before they occur across the continent. To substantiate their efforts, Illumina, a leading genomics company, has donated $1.4 million in equipment, software and reagents to the region through the ACDC (
 <xref rid="bib0015" ref-type="bibr">Devex, 2020</xref>).
</p>
